These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Julander JG; Shafer K; Smee DF; Morrey JD; Furuta Y Antimicrob Agents Chemother; 2009 Jan; 53(1):202-9. PubMed ID: 18955536 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Julander JG; Morrey JD; Blatt LM; Shafer K; Sidwell RW Antiviral Res; 2007 Feb; 73(2):140-6. PubMed ID: 17049380 [TBL] [Abstract][Full Text] [Related]
8. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure. Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756 [TBL] [Abstract][Full Text] [Related]
9. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus. Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604 [TBL] [Abstract][Full Text] [Related]
10. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122 [TBL] [Abstract][Full Text] [Related]
11. Remdesivir efficacy against yellow fever in a hamster model. Julander JG; Bunyan E; Jordan R; Porter DP Antiviral Res; 2022 Jul; 203():105331. PubMed ID: 35533777 [TBL] [Abstract][Full Text] [Related]
12. Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus). Rodrigues SG; da Rosa AP; Galler R; Barros VL; Vieira Cde M; da Rosa JF; Azevedo Rdo S; Nunes MR; da Rosa ES; Vasconcelos PF Rev Soc Bras Med Trop; 2004; 37 Suppl 2():69-74. PubMed ID: 15586900 [TBL] [Abstract][Full Text] [Related]
14. Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Julander JG; Ennis J; Turner J; Morrey JD Antimicrob Agents Chemother; 2011 May; 55(5):2067-73. PubMed ID: 21300837 [TBL] [Abstract][Full Text] [Related]
15. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses. Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of dengue virus by an ester prodrug of an adenosine analog. Chen YL; Yin Z; Lakshminarayana SB; Qing M; Schul W; Duraiswamy J; Kondreddi RR; Goh A; Xu HY; Yip A; Liu B; Weaver M; Dartois V; Keller TH; Shi PY Antimicrob Agents Chemother; 2010 Aug; 54(8):3255-61. PubMed ID: 20516277 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus. McArthur MA; Xiao SY; Barrett AD Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256 [TBL] [Abstract][Full Text] [Related]